RESUMO
RESUMEN La Endotelina-1 (ET1) y Proteína C Reactiva ultrasensible (PCRus) como marcadores de disfunción endotelial (DE) e inflamación vascular en hipotiroidismo subclínico (HS) han mostrado resultados controvertidos. El rol del estrés oxidativo y defensa antioxidante (TRAP) es motivo de discusión. Objetivos Establecer si el HS y la autoinmunidad tiroidea (AIT), excluyendo otros factores de riesgo cardiovascular, pueden causar DE e inflamación vascular, evaluadas a través de ET1 y PCRus, respectivamente. Establecer si TRAP juega algún rol. Evaluar cambios en ET1 y PCRus luego del tratamiento con levotiroxina (LT4). Material y métodos Se evaluaron prospectivamente 70 pacientes divididos en 3 grupos: HS: 41 pacientes (T4 normal,TSH >4,2 y <10 mUI/L), AIT: 10 pacientes eutiroideos (TSH <4,2 mUI/L) con aTPO y/o aTg (+) y Control: 19 pacientes eutiroideos sin AIT. Se excluyeron otros factores de riesgo cardiovascular. Se midió basalmente ET1, PCRus y TRAP plasmáticos, y en HS bajo LT4 (n = 24): ET1 y PCRus. Resultados No hubo diferencias significativas en edad, IMC, perfil lipídico y TRAP. ET1 y PCRus fueron significativamente mayores en pacientes con HS (media ± DS 1,77 ± 0,85 pg/ml y 1,5 ± 0,6 mg/l vs. controles (0,8 ± 0,3 pg/ml y 0,5 ± 0,2 mg/l) p <0,0001 y <0,008 respectivamente. Del mismo modo en AIT (1,4 ± 0.4 pg/ml y 2,3 ± 1,3 mg/l) vs controles p <0,0001 y <0,034, respectivamente. La TSH fue mayor en el grupo AIT vs. Control 2,57 ± 0,88 vs. 1,64 ± 0,5 mUI/L; p = 0,002. En HS bajo LT4 (8,7 ± 3,8 meses) se observó descenso de ET1 (p <0,001). ET1 correlacionó con TSH (r = 0,5 p <0,0001). El punto de corte de ET1 mediante curva ROC fue 1,32 pg/ml (Sensibilidad 81,6%-Especificidad 75%). Conclusiones ET1 y PCRus resultaron marcadores útiles para evaluar DE e inflamación vascular asociadas a HS. La defensa antioxidante no ejercería un rol en estos mecanismos. El tratamiento con LT4 produjo una significativa caída de ET1, pudiendo necesitarse un período más largo de eutiroidismo para normalizarla. En AIT, niveles de TSH >2,5 mUI/L podrían sugerir un mínimo grado de hipotiroidismo justificando la elevación en ET1 y PCR, sin descartar el rol de la AIT "per se".
ABSTRACT The measurement of endothelin-1 (ET1) and high sensitivity C-reactive protein (hsCRP) as markers of endothelial dysfunction (ED) and vascular inflammation in subclinical hypothyroidism (SH) has shown controversial results. The role of oxidative stress and antioxidant defense (TRAP) is a matter of discussion. Objectives To establish if SH and thyroid autoimmunity (TAI), excluding other cardiovascular risk factors, may cause ED and vascular inflammation, evaluated through the measurement of ET1 and hsCRP respectively. To determine if TRAP could have some role. Additionally, changes in these parameters after treatment with levothyroxine (LT4) will be evaluated. Material and methods: 70 patients were prospectively evaluated. They were classified into: SH Group: 41 patients (normal T4, TSH> 4.2 and <10 mIU/L), TAI Group: 10 euthyroid patients (TSH <4.2 mUI/L) with positive aTPO and/or aTg and Control Group: 19 euthyroid patients without TAI. Other cardiovascular risk factors were excluded in patients and controls. Plasma ET1, hsCRP and TRAP were measured basally, and ET1 and hsCRP under LT4 therapy in the HS Group. Results There were no significant differences between the 3 groups in age, BMI, lipids and TRAP. ET1 and hsCRP were significantly higher in patients with SH (mean ± SD 1.77 ± 0.85 pg/ml and 1.5 ± 0.6 mg/l) vs. controls (0.8 ± 0.3 pg/ml y 0.5 ± 0.2 mg/l) p <0.0001 y <0.008 respectively. Similarly, in TAI patients (1.4 ± 0.4 pg/ml y 2.3 ± 1.3 mg/l) vs controls, p <0.0001 and <0.034, respectively. TSH was higher in the TAI patients versus control group (2.5 ± 0.88 versus 1.64 ± 0.5 mIU/L, p = 0.002). Twenty-four patients with SH showed a significant decrease in ET1 (p <0.001) under treatment with LT4 (8.7 ± 3.8 months). ET1 had a highly significant correlation (p <0.0001) with TSH (r = 0.5). The cut-off level of ET1 established by ROC curve was 1.32 pg/ml (Sensitivity 81.6%-Specificity 75%). Conclusions ET1 and hsCRP were useful markers to evaluate ED and vascular inflammation associated with SH. There were no differences in TRAP levels between patients and controls, so it does not appear that oxidative stress would have played any role. Treatment with LT4 produced a significant drop in ET1. Probably, a longer period of euthyroidism might be necessary to normalize ET1 levels. In TAI Group, TSH levels >2.5 mUI/L could suggest a "minimal degree" of hypothyroidism justifying the elevation in ET1 and hs CRP. The role of the TAI "per se" couldn't be completely ruled out.
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Proteína C-Reativa/efeitos dos fármacos , Endotelina-1/efeitos dos fármacos , Hipotireoidismo/complicações , Tiroxina/uso terapêutico , Proteína C-Reativa/análise , Autoimunidade/efeitos dos fármacos , Estudos de Casos e Controles , Endotelina-1/análise , Antioxidantes/metabolismoRESUMO
BACKGROUND: The anti-inflammatory and cardioprotective properties of curcumin (Cur), a natural polyphenolic flavonoid isolated from the rhizomes of Curcuma longa, are increasingly considered to have beneficial effects on the progression of Chagas heart disease, caused by the protozoan parasite Trypanosoma cruzi. OBJECTIVE: To evaluate the effects of oral therapy with Cur on T. cruzi-mediated cardiovasculopathy in acutely infected mice and analyse the in vitro response of parasite-infected human microvascular endothelial cells treated with this phytochemical. METHODS: Inflammation of heart vessels from Cur-treated and untreated infected mice were analysed by histology, with benznidazole (Bz) as the reference compound. Parasitaemia was monitored by the direct method. Capillary permeability was visualised by Evans-blue assay. Myocardial ET-1, IL-6, and TNF-α mRNA expressions were measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Microvascular endothelial HMEC-1 cells were infected in vitro with or without addition of Cur or Bz. Induction of the Ca2+/NFAT pathway was assessed by fluorometry, immunoblotting, and reporter assay. FINDINGS: Oral Cur therapy of recently infected mice reduced inflammatory cell infiltration of myocardial arteries without lowering parasite levels. Compared to that of the phosphate-buffered saline-receiving group, hearts from Cur-treated mice showed significantly decreased vessel inflammation scores (p < 0.001), vascular permeabilities (p < 0.001), and levels of IL-6/TNF-α (p < 0.01) and ET-1 (p < 0.05) mRNA. Moreover, Cur significantly (p < 0.05 for transcript; p < 0.01 for peptide) downregulated ET-1 secretion from infected HMEC-1 cells. Remarkably, Cur addition significantly (p < 0.05 at 27.0 µM) interfered with T. cruzi-dependent activation of the Ca2+/NFATc1 signalling pathway that promotes generation of inflammatory agents in HMEC-1 cells. CONCLUSIONS: Oral treatment with Cur dampens cardiovasculopathy in acute Chagas mice. Cur impairs the Ca2+/NFATc1-regulated release of ET-1 from T. cruzi-infected vascular endothelium. These findings identify new perspectives for exploring the potential of Cur-based interventions to ameliorate Chagas heart disease.
Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Cardiomiopatia Chagásica/tratamento farmacológico , Curcumina/farmacologia , Endotelina-1/efeitos dos fármacos , Fatores de Transcrição NFATC/efeitos dos fármacos , Doença Aguda , Animais , Western Blotting , Permeabilidade Capilar/efeitos dos fármacos , Células Cultivadas , Cardiomiopatia Chagásica/metabolismo , Cardiomiopatia Chagásica/parasitologia , Progressão da Doença , Células Endoteliais/efeitos dos fármacos , Células Endoteliais/parasitologia , Endotelina-1/análise , Endotelina-1/metabolismo , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/parasitologia , Ensaio de Imunoadsorção Enzimática , Corantes Fluorescentes , Interleucina-6/sangue , Masculino , Camundongos Endogâmicos C57BL , Fatores de Transcrição NFATC/análise , Fatores de Transcrição NFATC/metabolismo , Reprodutibilidade dos Testes , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Tempo , Trypanosoma cruzi/efeitos dos fármacos , Fator de Necrose Tumoral alfa/sangueRESUMO
Purpose: To investigate changes in the plasma concentrations of cardiac troponin I (CTnI), thromboxane A2 (TXA2), prostaglandin I2 (PGI2) and endothelin-1 (ET-1) in rabbits with massive pulmonary embolism (AMPE) and the impact of nitric oxide inhalation (NOI) on these indices. Methods: A total of 30 Japanese rabbits were used to construct an MPE model and were divided into 3 groups equally (n=10), including an EXP group (undergoing modeling alone), an NOI group (receiving NOI 2 h post-modeling) and a CON group (receiving intravenous physiological saline). Results: In the model group, plasma concentration of CTnI peaked at 16 h following modeling (0.46±0.10 µg/ml) and significantly decreased following NOI. Plasma levels of TXB2, PGI2 and ET-1 peaked at 12, 16 and 8 h following modeling, respectively, and significantly decreased at different time points (0, 2, 4, 8, 12, 16, 20 and 24 h) following NOI. A significant correlation was observed between the peak plasma CTnI concentration and peak TXB2, 6-keto prostaglandin F1 and ET-1 concentrations in the model and NOI groups. Conclusion: Increases in plasma TXA2, PGI2 and ET-1 levels causes myocardial damage in a rabbit model of AMPE; however, NOI effectively down regulates the plasma concentration of these molecules to produce a myocardial-protective effect.(AU)
Assuntos
Animais , Coelhos , Óxido Nítrico/farmacologia , Óxido Nítrico/uso terapêutico , Embolia Pulmonar/terapia , Troponina I/análise , Tromboxano A2/análise , Dinoprostona/análise , Endotelina-1/análise , Administração por Inalação , Modelos Animais de DoençasRESUMO
Recent evidence shows that chronic ethanol consumption increases endothelin (ET)-1 induced sustained contraction of trabecular smooth muscle cells of the corpora cavernosa in corpus cavernosum of rats by a mechanism that involves increased expression of ETA and ETB receptors. Our goal was to evaluate the effects of alcohol and diabetes and their relationship to miRNA-155, miRNA-199 and endothelin receptors in the corpus cavernosum and blood of rats submitted to the experimental model of diabetes mellitus and chronic alcoholism. Forty-eight male Wistar rats were divided into four groups: control (C), alcoholic (A), diabetic (D), and alcoholic-diabetic (AD). Samples of the corpus cavernosum were prepared to study the protein expression of endothelin receptors by immunohistochemistry and expression of miRNAs-155 and -199 in serum and the cavernous tissue. Immunostaining for endothelin receptors was markedly higher in the A, D, and AD groups than in the C group. Moreover, a significant hypoexpression of the miRNA-199 in the corpus cavernosum tissue from the AD group was observed, compared to the C group. When analyzing the microRNA profile in blood, a significant hypoexpression of miRNA-155 in the AD group was observed compared to the C group. The miRNA-199 analysis demonstrated significant hypoexpression in D and AD groups compared to the C group. Our findings in corpus cavernosum showed downregulated miRNA-155 and miRNA-199 levels associated with upregulated protein expression and unaltered mRNA expression of ET receptors suggesting decreased ET receptor turnover, which can contribute to erectile dysfunction in diabetic rats exposed to high alcohol levels.
Assuntos
Alcoolismo/metabolismo , Diabetes Mellitus Experimental/metabolismo , Endotelina-1/análise , MicroRNAs/análise , Pênis/metabolismo , Receptor de Endotelina A/análise , Receptor de Endotelina B/análise , Alcoolismo/complicações , Alcoolismo/fisiopatologia , Animais , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Experimental/fisiopatologia , Imuno-Histoquímica , Masculino , Pênis/fisiopatologia , Ratos , Ratos WistarRESUMO
Recent evidence shows that chronic ethanol consumption increases endothelin (ET)-1 induced sustained contraction of trabecular smooth muscle cells of the corpora cavernosa in corpus cavernosum of rats by a mechanism that involves increased expression of ETA and ETB receptors. Our goal was to evaluate the effects of alcohol and diabetes and their relationship to miRNA-155, miRNA-199 and endothelin receptors in the corpus cavernosum and blood of rats submitted to the experimental model of diabetes mellitus and chronic alcoholism. Forty-eight male Wistar rats were divided into four groups: control (C), alcoholic (A), diabetic (D), and alcoholic-diabetic (AD). Samples of the corpus cavernosum were prepared to study the protein expression of endothelin receptors by immunohistochemistry and expression of miRNAs-155 and -199 in serum and the cavernous tissue. Immunostaining for endothelin receptors was markedly higher in the A, D, and AD groups than in the C group. Moreover, a significant hypoexpression of the miRNA-199 in the corpus cavernosum tissue from the AD group was observed, compared to the C group. When analyzing the microRNA profile in blood, a significant hypoexpression of miRNA-155 in the AD group was observed compared to the C group. The miRNA-199 analysis demonstrated significant hypoexpression in D and AD groups compared to the C group. Our findings in corpus cavernosum showed downregulated miRNA-155 and miRNA-199 levels associated with upregulated protein expression and unaltered mRNA expression of ET receptors suggesting decreased ET receptor turnover, which can contribute to erectile dysfunction in diabetic rats exposed to high alcohol levels.
Assuntos
Animais , Masculino , Ratos , Alcoolismo/metabolismo , Diabetes Mellitus Experimental/metabolismo , Endotelina-1/análise , MicroRNAs/análise , Pênis/metabolismo , Receptor de Endotelina A/análise , Receptor de Endotelina B/análise , Alcoolismo/complicações , Alcoolismo/fisiopatologia , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Experimental/fisiopatologia , Imuno-Histoquímica , Pênis/fisiopatologia , Ratos WistarRESUMO
INTRODUCTION: Rheumatic Fever represents a serious public health problem in developing countries, with thousands of new cases each year. It is an autoimmune disease, which occurs in response to infection by streptococcus A. OBJECTIVE: The aim of this study was to evaluate the immunolabeling and protein expression for endothelin-1 and 3 (ET-1, ET-3) and its receptors (ETA, ETB) in rheumatic mitral valves. METHODS: Immunohistochemistry was used to identify ET-1/ET-3 and ETA/ETB receptors in rheumatic and control mitral valves. Quantitative analysis of immunostaining for ET-1/ET-3 and ETA/ETB receptors was performed. In addition, western blot analysis was carried out to assess protein levels in tissue samples. RESULTS: ET-1 and ETA receptor immunostaining predominated in stenotic valves, mainly associated with fibrotic regions, inflammatory areas and neovascularization. Quantitative analysis showed that the average area with positive expression of ET-1 was 18.21 ± 14.96%. For ETA and ETB, the mean expressed areas were respectively 15.06 ± 13.13% and 9.20 ± 11.09%. ET-3 did not have a significant expression. The correlation between the expression of both endothelin receptors were strongly positive (R = 0.74, P = 0.02), but the correlation between ET-1 and its receptor were negative for both ETA (R = -0.37, P = 0.25), and ETB (R = -0.14, P = 0.39). This data was supported by western blot analysis. CONCLUSION: The strong correlation between ET-1 and its receptors suggests that both play a role in the pathophysiology of rheumatic mitral valve stenosis and may potentially act as biomarkers of this disease.
Assuntos
Endotelina-1/análise , Endotelina-3/análise , Estenose da Valva Mitral/patologia , Receptor de Endotelina A/análise , Receptor de Endotelina B/análise , Febre Reumática/patologia , Adulto , Biomarcadores/análise , Western Blotting , Cálcio/análise , Estudos de Casos e Controles , Feminino , Humanos , Imuno-Histoquímica , Masculino , Estenose da Valva Mitral/fisiopatologia , Valores de Referência , Febre Reumática/fisiopatologia , Adulto JovemRESUMO
Abstract Introduction: Rheumatic Fever represents a serious public health problem in developing countries, with thousands of new cases each year. It is an autoimmune disease, which occurs in response to infection by streptococcus A. Objective: The aim of this study was to evaluate the immunolabeling and protein expression for endothelin-1 and 3 (ET-1, ET-3) and its receptors (ETA, ETB) in rheumatic mitral valves. Methods: Immunohistochemistry was used to identify ET-1/ET-3 and ETA/ETB receptors in rheumatic and control mitral valves. Quantitative analysis of immunostaining for ET-1/ET-3 and ETA/ETB receptors was performed. In addition, western blot analysis was carried out to assess protein levels in tissue samples. Results: ET-1 and ETA receptor immunostaining predominated in stenotic valves, mainly associated with fibrotic regions, inflammatory areas and neovascularization. Quantitative analysis showed that the average area with positive expression of ET-1 was 18.21±14.96%. For ETA and ETB, the mean expressed areas were respectively 15.06±13.13% and 9.20±11.09%. ET-3 did not have a significant expression. The correlation between the expression of both endothelin receptors were strongly positive (R=0.74, P=0.02), but the correlation between ET-1 and its receptor were negative for both ETA (R=-0.37, P=0.25), and ETB (R=-0.14, P=0.39). This data was supported by western blot analysis. Conclusion: The strong correlation between ET-1 and its receptors suggests that both play a role in the pathophysiology of rheumatic mitral valve stenosis and may potentially act as biomarkers of this disease. .
Resumo Introdução: A febre reumática representa um sério problema de saúde pública em países em desenvolvimento, com milhares de novos casos a cada ano. Ela é uma doença autoimune que ocorre em resposta à infecção por estreptococos do grupo A. Objetivo: O objetivo deste estudo foi avaliar a expressão proteica e imunohistoquímica para a endotelina-1 e 3 (ET-1 e ET-3) e seus receptores (ETA e ETB) em valvas mitrais reumáticas. Métodos: Imunohistoquímica foi utilizada para identificar receptores de ET1/ET3 e ETA/ETB em valvas mitrais reumáticas e controles. A análise quantitativa da expressão imunohistoquímica para receptores de ET1/ET3 e ETA/ETB foi também efetuada. Adicionalmente, foi feita análise do western blot para mensurar níveis de proteínas em extratos tissulares. Resultados: A expressão imunohistoquímica de ET-1 e de seu receptor predominou em valvas estenóticas, estando associada com regiões fibróticas, áreas inflamatórias e neovascularização. A análise quantitativa mostrou que a área média com expressão positiva para ET-1 foi de 18,21±14,96%. Para o ETA e o ETB, as áreas médias expressas foram, respectivamente, 15,06±13,13% e 9,20±11,09%. ET-3 não teve uma expressão significante. A correlação entre a expressão dos dois receptores de endotelina foi fortemente positiva (R=0,74, P=0,02); mas a correlação entre ET-1 e o seu receptor foi negativa tanto para ETA (R=-0,37, P=0,25) como para ETB (R=-0,14, P=0,39). Estes dados foram confirmados pela análise do western blot. Conclusão: A forte correlação entre ET-1 e seus receptores sugere que ambos têm papel importante na fisiopatologia da estenose mitral reumática, podendo potencialmente atuar como biomarcadores desta doença. .
Assuntos
Adulto , Feminino , Humanos , Masculino , Adulto Jovem , Endotelina-1/análise , /análise , Estenose da Valva Mitral/patologia , Receptor de Endotelina A/análise , Receptor de Endotelina B/análise , Febre Reumática/patologia , Western Blotting , Biomarcadores/análise , Estudos de Casos e Controles , Cálcio/análise , Imuno-Histoquímica , Estenose da Valva Mitral/fisiopatologia , Valores de Referência , Febre Reumática/fisiopatologiaRESUMO
Oral squamous cell carcinoma (OSCC) is the most frequent malignant neoplasia of the oral cavity, which largely compromises the patient's life quality. Therefore, the identification of biomarkers for this kind of cancer is essential to provide a better diagnosis and prognosis for patients. Endothelin-1 is a peptide produced mainly by endothelial cells, and might be found in several body fluids, such as saliva, milk, urine, cerebrospinal fluid and plasma. It has been demonstrated that expression of this peptide is increased in a great number of neoplasias, including oral carcinoma. The identification of salivary biomarkers would be a useful tool for scanning and monitoring patients with risk of developing OSCC, as well to early detect recurrence, or the formation of a new primary tumor. In the present study, we have analyzed the levels of endothelin-1 in saliva obtained from patients with OSCC or oral leukoplakia, in comparison to healthy control patients. This study also evaluated the salivary ET-1 levels in patients with complete remission of OSCC. The results revealed no statistical difference in salivary endothelin-1 levels, neither in OSCC nor in oral leukoplakia, even when conditions such as elderly, sex and hypertension were taken into consideration. Although, ET-1 might display an important role in OSCC, its levels in saliva do not seem to be a good marker of neoplasias grade or malignant transformation.
Assuntos
Biomarcadores Tumorais/análise , Carcinoma de Células Escamosas/metabolismo , Endotelina-1/análise , Leucoplasia Oral/metabolismo , Neoplasias Bucais/metabolismo , Saliva/química , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Hyperuricemia is associated with increases in cardiovascular risk and renal disease. Mesangial cells regulate glomerular filtration rates through the release of hormones and vasoactive substances. This study evaluates the signaling pathway of uric acid (UA) in immortalized human mesangial cells (ihMCs). To evaluate cell proliferation, ihMCs were exposed to UA (6-10 mg/dL) for 24-144 h. In further experiments, ihMCs were treated with UA (6-10 mg/dL) for 12 and 24 h simultaneously with losartan (10(-7) mmol/L). Angiotensin II (AII) and endothelin-1 (ET-1) were assessed using the enzyme-linked immunosorbent assay (ELISA) technique. Pre-pro-ET mRNA was evaluated by the real-time PCR technique. It was observed that soluble UA (8 and 10 mg/dL) stimulated cellular proliferation. UA (10 mg/dL) for 12 h significantly increased AII protein synthesis and ET-1 expression and protein production was increased after 24 h. Furthermore, UA increased [Ca(2+)](i), and this effect was significantly blocked when ihMCs were preincubated with losartan. Our results suggested that UA triggers reactions including AII and ET-1 production in mesangial cells. In addition, UA can potentially affect glomerular function due to UA-induced proliferation and contraction of mesangial cells. The latter mechanism could be related to the long-term effects of UA on renal function and chronic kidney disease.
Assuntos
Angiotensina II/fisiologia , Cálcio/análise , Células Mesangiais/efeitos dos fármacos , Ácido Úrico/farmacologia , Angiotensina II/biossíntese , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Relação Dose-Resposta a Droga , Endotelina-1/análise , Ensaio de Imunoadsorção Enzimática , Humanos , Losartan/farmacologia , Células Mesangiais/química , Células Mesangiais/fisiologia , Reação em Cadeia da PolimeraseRESUMO
Maternal diabetes significantly increases the risk of congenital malformation, a syndrome known as diabetic embryopathy. Nitric oxide (NO), implicated in embryogenesis, has been found elevated in embryos from diabetic rats during organogenesis. The developmental signaling molecules endothelin-1 (ET-1) and 15-deoxy delta(12,14)prostaglandin J2 (15dPGJ2) downregulate embryonic NO levels. In the presence of NO and superoxide, formation of the potent oxidant peroxynitrite may occur. Therefore, we investigated peroxynitrite-induced damage, ET-1 and 15dPGJ2 concentrations, and the capability of ET-1, 15dPGJ2 and prostaglandin E2 (PGE2) to regulate NO production in embryos from severely diabetic rats (streptozotocin-induced before pregnancy). We found intense nitrotyrosine immunostaining (an index of peroxynitrite-induced damage) in neural folds, neural tube and developing heart of embryos from diabetic rats (P < 0.001 vs controls). We also found reduced ET-1 (P < 0.001) and 15dPGJ2 (P < 0.001) concentrations in embryos from diabetic rats when compared with controls. In addition, the inhibitory effect of ET-1, 15dPGJ2 and PGE2 on NO production found in control embryos was not observed in embryos from severely diabetic rats. In conclusion, both the demonstrated peroxynitrite-induced damage and the altered levels and function of multiple signaling molecules involved in the regulation of NO production provide supportive evidence of nitrosative stress in diabetic embryopathy.
Assuntos
Diabetes Mellitus Experimental/metabolismo , Embrião de Mamíferos/metabolismo , Óxido Nítrico/metabolismo , Organogênese/fisiologia , Gravidez em Diabéticas/metabolismo , Tirosina/análogos & derivados , Animais , Embrião de Mamíferos/química , Endotelina-1/análise , Feminino , Imuno-Histoquímica/métodos , Nitratos/análise , Nitritos/análise , Gravidez , Prostaglandina D2/análogos & derivados , Prostaglandina D2/análise , Ratos , Ratos Wistar , Tirosina/análiseRESUMO
A endotelina é um peptídeo vasoconstrictor potente que possui funções angiogênicas, mitogênicas e neurotróficas. Neste estudo procurou-se quantificar os níveis de Endotelina -1 (ET-1) em vilos coriônicos placentários e no âmnio de placentas de fetos gemelares, cujas mães submeteram-se à reprodução assistida e fecundação espontânea. Foram colhidas oito amostras de placentas, que após o delivramento placentário, foram colocadas em nitrogênio líquido e, posteriormente, congeladas e mantidas à -80°C até o processamento por ensaio imunoenzimático (ELISA). Os níveis de concentração de ET-1 em amostras de vilos coriônicos de placentas de fetos gemelares variaram de 0,52 a 0,70fmol/ml, enquanto que de fetos únicos variou de 0,47 a 0,86fmol/ml. A mesma determinação em amostras de âmnio de placentas de gemelares variou de 0,61 a 1,16 fmol/ml, enquanto que de fetos únicos variou de 0,65 a 1,04fmol/ml. Estes achados indicam que em vilos coriônicos, os níveis de concentração de ET-1 não variaram entre gemelares e fetos únicos. No âmnio, os níveis de ET-1 são mais elevados em gemelares que em fetos únicos, dados que sugerem que o âmnio é a principal fonte de ET-1 presente no líquido amniótico.
The endothelin is a potent vasoconstricor that possess angiogenic, mitogenic and neurotrophical functions. In this study we aimed to quantify the Endothelin-1 (ET-1) levels in chorionic placental villi and amnion of placentae of twins childbirths whose women were submitted to an assisted pregnancy and spontaneal fecundation. Were collected 08 placental samples. After the placental delivery the samples had been placed in liquid nitrogen and later in a -80°C until the Enzyme-Linked Immunosorbent Assay (ELISA) technique. The concentration levels of ET-1 in samples of chorionic villi in twins placentae varied from 0,52 to 0,70 fmol/ml, while in chorionic villi single gestation varied from 0,47 to 0,86 fmol/ml. The same determination in samples of amnion of twins placentae varied from 0,65 to 1,16 fmol/ml, while in single gestation varied from 0,65 to 1,04 fmol/ml. These findings suggests that in the chorionic villi the levels of ET-1 didn't vary between twins and single gestation. In the amnion the levels of ET-1 are higher in twins than in single gestation, suggesting that the amnion is the source of ET-1 in the amniotic fluid.
Assuntos
Humanos , Ensaio de Imunoadsorção Enzimática , Membranas Extraembrionárias , Endotelina-1/análise , Fertilização in vitro/métodos , Placenta/metabolismo , Técnicas ReprodutivasRESUMO
A endotelina é um peptídeo vasoconstrictor potente que possui funções angiogênicas, mitogênicas e neurotróficas. Neste estudo procurou-se quantificar os níveis de Endotelina -1 (ET-1) em vilos coriônicos placentários e no âmnio de placentas de fetos gemelares, cujas mães submeteram-se à reprodução assistida e fecundação espontânea. Foram colhidas oito amostras de placentas, que após o delivramento placentário, foram colocadas em nitrogênio líquido e, posteriormente, congeladas e mantidas à -80ºC até o processamento por ensaio imunoenzimático (ELISA). Os níveis de concentração de ET-1 em amostras de vilos coriônicos de placentas de fetos gemelares variaram de 0,52 a 0,70fmol/ml, enquanto que de fetos únicos variou de 0,47 a 0,86fmol/ml. A mesma determinação em amostras de âmnio de placentas de gemelares variou de 0,61 a 1,16 fmol/ml, enquanto que de fetos únicos variou de 0,65 a 1,04fmol/ml. Estes achados indicam que em vilos coriônicos, os níveis de concentração de ET-1 não variaram entre gemelares e fetos únicos. No âmnio, os níveis de ET-1 são mais elevados em gemelares que em fetos únicos, dados que sugerem que o âmnio é a principal fonte de ET-1 presente no líquido amniótico.(AU)
The endothelin is a potent vasoconstricor that possess angiogenic, mitogenic and neurotrophical functions. In this study we aimed to quantify the Endothelin-1 (ET-1) levels in chorionic placental villi and amnion of placentae of twins childbirths whose women were submitted to an assisted pregnancy and spontaneal fecundation. Were collected 08 placental samples. After the placental delivery the samples had been placed in liquid nitrogen and later in a -80ºC until the Enzyme-Linked Immunosorbent Assay (ELISA) technique. The concentration levels of ET-1 in samples of chorionic villi in twins placentae varied from 0,52 to 0,70 fmol/ml, while in chorionic villi single gestation varied from 0,47 to 0,86 fmol/ml. The same determination in samples of amnion of twins placentae varied from 0,65 to 1,16 fmol/ml, while in single gestation varied from 0,65 to 1,04 fmol/ml. These findings suggests that in the chorionic villi the levels of ET-1 didn't vary between twins and single gestation. In the amnion the levels of ET-1 are higher in twins than in single gestation, suggesting that the amnion is the source of ET-1 in the amniotic fluid.(AU)